Silk Road Medical (NASDAQ:SILK) Downgraded by Zacks Investment Research to Hold

Silk Road Medical} stock has undergone multiple analysts rating changes in the recent past.  Silk Road Medical Downgraded by Zacks Investment Research on 10/30/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Silk Road Medical (NASDAQ:SILK) Downgraded by Zacks Investment Research to Hold